15.8  -2.2 (-12.22%)		05-13 13:12
Open: 15.4 High: 17.43 Volume: 57,116		Pre. Close: 18 Low: 14.2 Market Cap: 341(M)

Short term
Mid term
Targets	6-month :	54.56	1-year :	78.04
Resists	First :	46.71	Second :	66.81
Pivot price	20.19
Supports	First :	14.19	Second :	11.81
MAs	MA(5) :	19.56	MA(20) :	19.44
	MA(100) :	17.25	MA(250) :	13.2
MACD	MACD :	1.2	Signal :	1.6
%K %D	K(14,3) :	6.2	D(3) :	9.3
RSI	RSI(14): 47.3
52-week	High :	133.11	Low :	2.75

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ PHOE ] has closed above bottom band by 38.1%. Bollinger Bands are 37.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	19.55 - 19.66	19.66 - 19.78
Low:	16.1 - 16.2	16.2 - 16.32
Close:	17.78 - 17.98	17.98 - 18.2

Phoenix Asia Holdings Limited engages in the substructure works in Hong Kong. The company undertakes site formation, ground investigation and foundation works. It also provides construction services, such as structural steelworks. The company was incorporated in 2024 and is based in Kowloon Bay, Hong Kong. Phoenix Asia Holdings Limited is a subsidiary of Phoenix Asia Holdings Limited.

Fri, 08 May 2026
Phoenix Asia Holdings (PHOE) Stock Surges Over 47% After Hours: Here's Why - Benzinga

Thu, 07 May 2026
Why Is Phoenix Asia Stock Gaining Today? - Benzinga

Tue, 05 May 2026
Scilex Holding Company Announces Its Subsidiaries, ACEA - GlobeNewswire

Mon, 04 May 2026
Phoenix Asia Holdings Limited Announces Entering into Stock Acquisition Agreement and Convertible Promissory Note - The Manila Times

Mon, 04 May 2026
Phoenix Asia (NASDAQ: PHOE) pivots to pharma with $1B ACEA acquisition - Stock Titan

Mon, 04 May 2026
Hong Kong builder strikes drug-company deal, adds $20M note - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Industrials
Industry: Construction
Shares Out	22 (M)
Shares Float	6 (M)
Held by Insiders	74.5 (%)
Held by Institutions	0 (%)
Shares Short	3 (K)
Shares Short P.Month	3 (K)

EPS	0.02
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.34
Profit Margin	8.3 %
Operating Margin	6 %
Return on Assets (ttm)	7.2 %
Return on Equity (ttm)	11.6 %
Qtrly Rev. Growth	-7.4 %
Gross Profit (p.s.)	0.08
Sales Per Share	0.32
EBITDA (p.s.)	0.03
Qtrly Earnings Growth	-76.1 %
Operating Cash Flow	-4 (M)
Levered Free Cash Flow	-3 (M)

PE Ratio	546.33
PEG Ratio	0
Price to Book value	46.82
Price to Sales	49.93
Price to Cash Flow	-83.11

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.